Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Maintains InLine Rating on Inspirato with Revised Price Target

Elaine Mendonca by Elaine Mendonca
March 7, 2024
in Breaking News
0
Unlocking Value: The Economic Potential of Iron-Titanium-Vanadium Projects
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

On March 7, 2024, Shweta Khajuria, an analyst at Evercore ISI Group, has decided to maintain her In-Line rating on Inspirato (NASDAQ: ISPO) but has revised the price target from $4 to $3. This change in valuation is a result of Khajuria’s careful evaluation of Inspirato’s performance and the current market environment.

Khajuria’s analysis suggests that while Inspirato has potential, there are factors at play that have led to a more conservative price target. This adjustment takes into account various market conditions and the company’s overall outlook.

ISPO Stock Performance Analysis: Potential for Growth Despite After-Hours Drop

On March 7, 2024, ISPO stock showed mixed performance throughout the day. The stock closed at $4.53, a $0.07 increase from the previous market close, representing a 1.57% rise. After-hours trading saw the stock drop $0.33 to $4.20, possibly due to market volatility, investor sentiment, or company-specific news.

ISPO is still trading near the bottom of its 52-week range and above its 200-day simple moving average, indicating potential for growth if it maintains its current position. Investors should monitor ISPO stock in the coming days to see if it can bounce back from the after-hours drop. Conducting thorough research and analysis before making investment decisions is crucial due to the volatility and unpredictability of stock prices.

ISPO Stock Performance Analysis: Revenue and Net Income Decline in 2024

On March 7, 2024, ISPO stock experienced a mixed performance based on the latest financial data provided by CNN Money. The company’s total revenue for the past year was reported at $329.10 million, with a significant decrease of 4.76% compared to the previous year. In the fourth quarter, ISPO generated $70.71 million in total revenue, reflecting a 14.39% decrease since the previous quarter.

Net income for ISPO was reported at -$51.76 million for the past year, showing a substantial decrease of 115.13% compared to the previous year. However, there was a 47.25% increase in net income since the last quarter, with a reported figure of -$8.79 million.

Earnings per share (EPS) for ISPO were -$15.31 for the past year, indicating a 66.48% decrease compared to the previous year. In the fourth quarter, the EPS was reported at -$2.51, showing no change since the previous quarter.

Overall, ISPO’s financial performance on March 7, 2024, reflected a decline in total revenue and net income compared to the previous year. However, there was a slight improvement in net income since the last quarter. The EPS remained stable from the previous quarter but showed a significant decrease compared to the previous year.

Tags: ISPO
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Information Technology Stock Market Today

Ciena Faces Stock Decline Despite Revenue Surpassing Expectations

Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Brera Holdings NASDAQ BREA Shows Growth Potential with Executive Chairmans Increased Ownership Stake and Strategic Expansion Plans

DrugRetailers Stock Exchange

American Eagle Outfitters Forecasts 220 Million Depreciation and Amortization Expenses with Optimistic Sales Growth

Recommended

Upcoming FDA Advisory Committee Meeting for Imetelstat A Groundbreaking Treatment for Malignant Stem Cells

2 years ago
Portillo's Stock

Leadership Turmoil Sends Portillo’s Shares to New Low

2 months ago
Dine Brands Global Stock

Dine Brands Stock Faces Potential Downturn

1 month ago
Intel Stock

US Government Considers Taking Equity Stake in Intel

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Procter & Gamble Shares Approach a Critical Juncture

Trending

XRP Stock
Analysis

XRP Market Dynamics: Institutional Pause Meets Accumulation Surge

by Andreas Sommer
January 11, 2026
0

The XRP market is currently defined by a stark divergence in investor behavior. After a powerful rally...

Rocket Lab USA Stock

Rocket Lab’s Stock Momentum Continues Unabated in 2026

January 11, 2026
Eli Lilly Stock

Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

January 11, 2026
Alibaba Stock

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

January 11, 2026
Vulcan Energy Stock

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • XRP Market Dynamics: Institutional Pause Meets Accumulation Surge
  • Rocket Lab’s Stock Momentum Continues Unabated in 2026
  • Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com